2/20/09
Duke Medicine News and Communications

Scientists at Duke University Medical Center and Johns Hopkins University have discovered mutations in two genes that could become therapeutic targets in malignant glioma, a dangerous class of brain tumors.

12/5/08
Lauren Shaftel Williams , (919) 684-4966
shaft001@mc.duke.edu

Georgia Schweitzer Beasley was one of the best women’s basketball players Duke has ever seen. She won ACC player of the year honors twice, was a first-team All American and played for the WNBA for three seasons. But even as an undergraduate at Duke, Georgia knew there would be a life beyond basketball; she aspired to be a surgeon. Planning for that future was a tall order, though, with practice, games and travel taking up the majority of her time.

9/26/2008

DURHAM -- Darell Bigner, director of The Preston Robert Tisch Brain Tumor Center at Duke, has been awarded the Zuelch Prize, Germany's most prestigious award for basic neurological research.

5/14/2008
Lauren Shaftel Williams , (919) 684-4966
shaft001@mc.duke.edu

DURHAM, N.C. -- The Pediatric Brain Tumor Foundation (PBTF) is giving $6 million to its research institute at Duke University to further the work started by a $6 million grant it gave in 2003 to create the institute, Duke President Richard H. Brodhead and Chancellor for Health Affairs Victor J. Dzau, M.D., announced Wednesday.

Stephen T. Keir, MPH, DrPH, Receives Young Investigator Award at the Chicago Supportive Oncology Conference, September 27–29, 2007.

An experimental brain tumor vaccine coaxes the immune system to attack diseased cells only. Trials on othercancers may follow.
By Bruce Goldman Special to The Los Angeles Times
January 14, 2008

Metro Magazine Who’s Who January 2008

By Rick Smith
www.metronc.com

1/4/2008
media contact: Jaymes Powell, Jr., Staff Writer
The News & Observer
(919) 829-4556 or jaymes.powell@newsobserver.com

10/29/2007
media contact: Lauren Shaftel , (919) 684-4966
shaft001@mc.duke.edu